Format
Items per page
Sort by

Send to:

Choose Destination

Results: 19

Cited In for PubMed (Select 15207261)

1.

Glioma Malignancy-Dependent NDRG2 Gene Methylation and Downregulation Correlates with Poor Patient Outcome.

Skiriutė D, Steponaitis G, Vaitkienė P, Mikučiūnas M, Skauminas K, Tamašauskas A, Kazlauskas A.

J Cancer. 2014 May 13;5(6):446-56. doi: 10.7150/jca.9140. eCollection 2014.

2.

Loss of NDRG2 expression activates PI3K-AKT signalling via PTEN phosphorylation in ATLL and other cancers.

Nakahata S, Ichikawa T, Maneesaay P, Saito Y, Nagai K, Tamura T, Manachai N, Yamakawa N, Hamasaki M, Kitabayashi I, Arai Y, Kanai Y, Taki T, Abe T, Kiyonari H, Shimoda K, Ohshima K, Horii A, Shima H, Taniwaki M, Yamaguchi R, Morishita K.

Nat Commun. 2014 Feb 26;5:3393. doi: 10.1038/ncomms4393.

3.

NDRG2 is a novel p53-associated regulator of apoptosis in C6-originated astrocytes exposed to oxygen-glucose deprivation.

Li Y, Xu N, Cai L, Gao Z, Shen L, Zhang Q, Hou W, Zhong H, Wang Q, Xiong L.

PLoS One. 2013;8(2):e57130. doi: 10.1371/journal.pone.0057130. Epub 2013 Feb 22.

4.

Widespread splicing changes in human brain development and aging.

Mazin P, Xiong J, Liu X, Yan Z, Zhang X, Li M, He L, Somel M, Yuan Y, Phoebe Chen YP, Li N, Hu Y, Fu N, Ning Z, Zeng R, Yang H, Chen W, Gelfand M, Khaitovich P.

Mol Syst Biol. 2013;9:633. doi: 10.1038/msb.2012.67.

5.

Expression of NDRG2 in human lung cancer and its correlation with prognosis.

Li SJ, Wang WY, Li B, Chen B, Zhang B, Wang X, Chen CS, Zhao QC, Shi H, Yao L.

Med Oncol. 2013 Mar;30(1):421. doi: 10.1007/s12032-012-0421-7. Epub 2013 Jan 10.

6.

Interaction of PDK1 with phosphoinositides is essential for neuronal differentiation but dispensable for neuronal survival.

Zurashvili T, Cordón-Barris L, Ruiz-Babot G, Zhou X, Lizcano JM, Gómez N, Giménez-Llort L, Bayascas JR.

Mol Cell Biol. 2013 Mar;33(5):1027-40. doi: 10.1128/MCB.01052-12. Epub 2012 Dec 28.

7.

Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs.

Lagier-Tourenne C, Polymenidou M, Hutt KR, Vu AQ, Baughn M, Huelga SC, Clutario KM, Ling SC, Liang TY, Mazur C, Wancewicz E, Kim AS, Watt A, Freier S, Hicks GG, Donohue JP, Shiue L, Bennett CF, Ravits J, Cleveland DW, Yeo GW.

Nat Neurosci. 2012 Nov;15(11):1488-97. doi: 10.1038/nn.3230. Epub 2012 Sep 30.

8.

NDRG2 Promotes GATA-1 Expression through Regulation of the JAK2/STAT Pathway in PMA-stimulated U937 Cells.

Kang K, Jung H, Nam S, Lim JS.

Immune Netw. 2011 Dec;11(6):348-57. doi: 10.4110/in.2011.11.6.348. Epub 2011 Dec 31.

9.

Up-regulation of NDRG2 in senescent lens epithelial cells contributes to age-related cataract in human.

Zhang ZF, Zhang J, Hui YN, Zheng MH, Liu XP, Kador PF, Wang YS, Yao LB, Zhou J.

PLoS One. 2011;6(10):e26102. doi: 10.1371/journal.pone.0026102. Epub 2011 Oct 17.

10.

Crystal structure of the human N-Myc downstream-regulated gene 2 protein provides insight into its role as a tumor suppressor.

Hwang J, Kim Y, Kang HB, Jaroszewski L, Deacon AM, Lee H, Choi WC, Kim KJ, Kim CH, Kang BS, Lee JO, Oh TK, Kim JW, Wilson IA, Kim MH.

J Biol Chem. 2011 Apr 8;286(14):12450-60. doi: 10.1074/jbc.M110.170803. Epub 2011 Jan 18.

11.

Expression profile of the N-myc Downstream Regulated Gene 2 (NDRG2) in human cancers with focus on breast cancer.

Lorentzen A, Lewinsky RH, Bornholdt J, Vogel LK, Mitchelmore C.

BMC Cancer. 2011 Jan 12;11:14. doi: 10.1186/1471-2407-11-14.

12.

Phosphoproteomic analysis reveals site-specific changes in GFAP and NDRG2 phosphorylation in frontotemporal lobar degeneration.

Herskowitz JH, Seyfried NT, Duong DM, Xia Q, Rees HD, Gearing M, Peng J, Lah JJ, Levey AI.

J Proteome Res. 2010 Dec 3;9(12):6368-79. doi: 10.1021/pr100666c. Epub 2010 Oct 22.

13.

NDRG2 suppresses the proliferation of clear cell renal cell carcinoma cell A-498.

Ma JJ, Liao CG, Jiang X, Zhao HD, Yao LB, Bao TY.

J Exp Clin Cancer Res. 2010 Jul 30;29:103. doi: 10.1186/1756-9966-29-103.

14.

Tissue profiling of the mammalian central nervous system using human antibody-based proteomics.

Mulder J, Björling E, Jonasson K, Wernérus H, Hober S, Hökfelt T, Uhlén M.

Mol Cell Proteomics. 2009 Jul;8(7):1612-22. doi: 10.1074/mcp.M800539-MCP200. Epub 2009 Apr 7.

15.

NDRG2 expression decreases with tumor stages and regulates TCF/beta-catenin signaling in human colon carcinoma.

Kim YJ, Yoon SY, Kim JT, Song EY, Lee HG, Son HJ, Kim SY, Cho D, Choi I, Kim JH, Kim JW.

Carcinogenesis. 2009 Apr;30(4):598-605. doi: 10.1093/carcin/bgp047. Epub 2009 Feb 23.

16.

Reduced expression of N-Myc downstream-regulated gene 2 in human thyroid cancer.

Zhao H, Zhang J, Lu J, He X, Chen C, Li X, Gong L, Bao G, Fu Q, Chen S, Lin W, Shi H, Ma J, Liu X, Ma Q, Yao L.

BMC Cancer. 2008 Oct 22;8:303. doi: 10.1186/1471-2407-8-303.

17.

N-Myc downstream-regulated gene 2 is involved in p53-mediated apoptosis.

Liu N, Wang L, Li X, Yang Q, Liu X, Zhang J, Zhang J, Wu Y, Ji S, Zhang Y, Yang A, Han H, Yao L.

Nucleic Acids Res. 2008 Sep;36(16):5335-49. doi: 10.1093/nar/gkn504. Epub 2008 Aug 9.

18.

Expression of NDRG2 is down-regulated in high-risk adenomas and colorectal carcinoma.

Lorentzen A, Vogel LK, Lewinsky RH, Saebø M, Skjelbred CF, Godiksen S, Hoff G, Tveit KM, Lothe IM, Ikdahl T, Kure EH, Mitchelmore C.

BMC Cancer. 2007 Oct 12;7:192.

19.

Genetic networks controlling retinal injury.

Vazquez-Chona FR, Khan AN, Chan CK, Moore AN, Dash PK, Hernandez MR, Lu L, Chesler EJ, Manly KF, Williams RW, Geisert EE Jr.

Mol Vis. 2005 Nov 4;11:958-70.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk